Clinical Trial

Intervention of Bladder Cancer by CAR-T

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a Phase I/II and multicenter study designed to evaluate the efficacy and safety of 4SCAR-T cells in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have no further treatment available.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2017-06-10; most recent amendment 2026-06-18.
Trial Details
NCT Number NCT03185468
Lead Sponsor Shenzhen Geno-Immune Medical Institute
Conditions Bladder Cancer, Urothelial Carcinoma Bladder
Enrollment 20 participants
Start Date 2025-08-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23